Cargando…
Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study
INTRODUCTION: Fibrinogen levels drop quicker than any other factors in severe trauma such as Traumatic Brain Injury (TBI). Contemporaneous studies show that fibrinogen concentrations < 2 g/L are strongly related to mortality. However, little is known regarding fibrinogen levels and TBI severity a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002822/ https://www.ncbi.nlm.nih.gov/pubmed/36909492 http://dx.doi.org/10.21203/rs.3.rs-2596161/v1 |
_version_ | 1784904467536150528 |
---|---|
author | Ssenyondwa, John Baptist Kiryabwire, Joel Kaddumukasa, Martin Michael, Devereaux Kamabu, Larrey Kasereka Galukande, Moses Kaddumukasa, Mark Sajatovic, Martha Makumbi, Timothy Kabanda |
author_facet | Ssenyondwa, John Baptist Kiryabwire, Joel Kaddumukasa, Martin Michael, Devereaux Kamabu, Larrey Kasereka Galukande, Moses Kaddumukasa, Mark Sajatovic, Martha Makumbi, Timothy Kabanda |
author_sort | Ssenyondwa, John Baptist |
collection | PubMed |
description | INTRODUCTION: Fibrinogen levels drop quicker than any other factors in severe trauma such as Traumatic Brain Injury (TBI). Contemporaneous studies show that fibrinogen concentrations < 2 g/L are strongly related to mortality. However, little is known regarding fibrinogen levels and TBI severity as well as mortality in sub-Saharan Africa. We therefore set out to determine whether fibrinogen levels are associated with TBI severity and seven days outcomes. OBJECTIVES: To determine the sensitivity and specificity of fibrinogen levels and the association with severity and mortality among TBI patients at Mulago Hospital. METHODS: We prospectively enrolled 213 patients with TBI aged between 13 and 60 years of age and presenting within 24hrs of injury. Patients with pre-existing coagulopathy, concurrent use of anticoagulant or antiplatelet agents, pre-existing hepatic insufficiency, diabetes mellitus and who were pregnant were excluded. Fibrinogen levels were determined using the Clauss fibrinogen assay. RESULTS: Majority of the patients were male (88.7%) and nearly half were aged 30 or less (48.8%). Fibrinogen levels less than 2g/L were observed in 74 (35.1%) of the patients while levels above 4.5 g/L were observed in 30(14.2%) of the patients. The average time spent in the study was 3.7 ± 2.4 days. The sensitivity and specificity using fibrinogen < 2g/L was 56.5% and 72.9% respectively. Fibrinogen levels predict TBI severity with an AUC = 0.656 (95% CI 0.58–0.73: p = 0.000) Fibrinogen levels < 2g/L (hypofibrinogenemia) were independently associated with severe TBI. (AOR 2.87 CI,1.34–6.14: p = 0.007). Levels above 4.5g/L were also independently associated with injury severity (AOR 2.89, CI 1.12–7.48: p < 0.05) Fibrinogen levels more than 4.5g/L were independently associated with mortality (OR 4.5, CI;1.47–13.61, p < 0.05). CONCLUSIONS: The fibrinogen level is a useful tool in predicting severity including mortality of TBI in our settings. We recommend the routine use of fibrinogen levels in TBI patient evaluations as levels below 2g/L and levels above 4.5g/L are associated with severe injuries and mortality |
format | Online Article Text |
id | pubmed-10002822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-100028222023-03-11 Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study Ssenyondwa, John Baptist Kiryabwire, Joel Kaddumukasa, Martin Michael, Devereaux Kamabu, Larrey Kasereka Galukande, Moses Kaddumukasa, Mark Sajatovic, Martha Makumbi, Timothy Kabanda Res Sq Article INTRODUCTION: Fibrinogen levels drop quicker than any other factors in severe trauma such as Traumatic Brain Injury (TBI). Contemporaneous studies show that fibrinogen concentrations < 2 g/L are strongly related to mortality. However, little is known regarding fibrinogen levels and TBI severity as well as mortality in sub-Saharan Africa. We therefore set out to determine whether fibrinogen levels are associated with TBI severity and seven days outcomes. OBJECTIVES: To determine the sensitivity and specificity of fibrinogen levels and the association with severity and mortality among TBI patients at Mulago Hospital. METHODS: We prospectively enrolled 213 patients with TBI aged between 13 and 60 years of age and presenting within 24hrs of injury. Patients with pre-existing coagulopathy, concurrent use of anticoagulant or antiplatelet agents, pre-existing hepatic insufficiency, diabetes mellitus and who were pregnant were excluded. Fibrinogen levels were determined using the Clauss fibrinogen assay. RESULTS: Majority of the patients were male (88.7%) and nearly half were aged 30 or less (48.8%). Fibrinogen levels less than 2g/L were observed in 74 (35.1%) of the patients while levels above 4.5 g/L were observed in 30(14.2%) of the patients. The average time spent in the study was 3.7 ± 2.4 days. The sensitivity and specificity using fibrinogen < 2g/L was 56.5% and 72.9% respectively. Fibrinogen levels predict TBI severity with an AUC = 0.656 (95% CI 0.58–0.73: p = 0.000) Fibrinogen levels < 2g/L (hypofibrinogenemia) were independently associated with severe TBI. (AOR 2.87 CI,1.34–6.14: p = 0.007). Levels above 4.5g/L were also independently associated with injury severity (AOR 2.89, CI 1.12–7.48: p < 0.05) Fibrinogen levels more than 4.5g/L were independently associated with mortality (OR 4.5, CI;1.47–13.61, p < 0.05). CONCLUSIONS: The fibrinogen level is a useful tool in predicting severity including mortality of TBI in our settings. We recommend the routine use of fibrinogen levels in TBI patient evaluations as levels below 2g/L and levels above 4.5g/L are associated with severe injuries and mortality American Journal Experts 2023-03-01 /pmc/articles/PMC10002822/ /pubmed/36909492 http://dx.doi.org/10.21203/rs.3.rs-2596161/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Ssenyondwa, John Baptist Kiryabwire, Joel Kaddumukasa, Martin Michael, Devereaux Kamabu, Larrey Kasereka Galukande, Moses Kaddumukasa, Mark Sajatovic, Martha Makumbi, Timothy Kabanda Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title | Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title_full | Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title_fullStr | Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title_full_unstemmed | Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title_short | Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: a prospective study |
title_sort | fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in sub-saharan africa: a prospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002822/ https://www.ncbi.nlm.nih.gov/pubmed/36909492 http://dx.doi.org/10.21203/rs.3.rs-2596161/v1 |
work_keys_str_mv | AT ssenyondwajohnbaptist fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT kiryabwirejoel fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT kaddumukasamartin fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT michaeldevereaux fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT kamabularreykasereka fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT galukandemoses fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT kaddumukasamark fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT sajatovicmartha fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy AT makumbitimothykabanda fibrinogenapredictorofinjuryseverityandmortalityamongpatientswithtraumaticbraininjuryinsubsaharanafricaaprospectivestudy |